Pfizer-BioNTech
1st Dose
For: Ages 6 months+
2nd Dose
For: Ages 6 months+ | 21 days after 1st Dose
3rd Dose
For: Ages 6 months – 4 years | 56 days after 2nd Dose
For: Immunocompromised (ages 5+) | 28 days after 2nd Dose
Booster (Bivalent)
For: Ages 6 months - 4 years who have not yet begun their three-dose primary series of the Pfizer-BioNTech COVID-19 Vaccine or have not yet received the third dose of their primary series will now receive the updated (bivalent) Pfizer-BioNTech COVID-19 vaccine as the third dose in their primary series following two doses of the original (monovalent) Pfizer-BioNTech COVID-19 Vaccine.
For: Ages 5+ | 2 months after completion of COVID-19 vaccine primary series or previous booster
Moderna
1st Dose
For: Ages 6 months+
2nd Dose
For: Age 6 months+ | 28 days after 1st Dose
3rd Dose
For: Immunocompromised (ages 6 months+) | 28 days after 2nd Dose
Booster (Bivalent)
For: Ages 6 months - 5 years | 2 months after completion of COVID-19 vaccine primary series
For: Ages 6+ | 2 months after completion of COVID-19 vaccine primary series or previous booster
Novavax*
1st Dose
For: Ages 12+
2nd Dose
For: Age 12+ | 21 days after 1st Dose
Booster
For: Ages 18 years and older | 6 months after completion of COVID-19 vaccine primary series
*mRNA vaccines are preferred, but the Novavax COVID-19 vaccine may be considered in some situations.